The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Partial Agonists Activate PPARγ Using a Helix 12 Independent Mechanism
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675
A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
Shiau, A. K., Barstad, D., Loria, P. M., Cheng, L., Kushner, P. J., Agard, D. A., & Greene, G. L. (1998) · Cell · doi:10.1016/s0092-8674(00)81717-1 · Cited by 2,729
Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4318 · Cited by 2,164
Nuclear Receptors and Lipid Physiology: Opening the X-Files
Chawla, A., Repa, J. J., Evans, R. M., & Mangelsdorf, D. J. (2001) · Science · doi:10.1126/science.294.5548.1866 · Cited by 2,085
Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ
Nolte, R. T., Wisely, G. B., Westin, S., Cobb, J. E., Lambert, M. H., Kurokawa, R., Rosenfeld, M. G., Willson, T. M., Glass, C. K., & Milburn, M. V. (1998) · Nature · doi:10.1038/25931 · Cited by 1,958
Kliewer, S. A., Umesono, K., Noonan, D. J., Heyman, R. A., & Evans, R. M. (1992) · Nature · doi:10.1038/358771a0 · Cited by 1,741
Rosenfeld, M. G., Lunyak, V. V., & Glass, C. K. (2006) · Genes & Development · doi:10.1101/gad.1424806 · Cited by 952
Göttlicher, M., Widmark, E., Li, Q., & Gustafsson, J. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4653 · Cited by 857
PPARs: therapeutic targets for metabolic disease
Berger, J. P., Akiyama, T. E., & Meinke, P. T. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.03.003 · Cited by 713
Stols, L., Gu, M., Dieckman, L., Raffen, R., Collart, F. R., & Donnelly, M. I. (2002) · Protein Expression and Purification · doi:10.1006/prep.2001.1603 · Cited by 526
Thiazolidinediones: a new class of antidiabetic drugs
Day, C. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00023.x · Cited by 436
Mechanism of corepressor binding and release from nuclear hormone receptors
Nagy, L., Kao, H.-Y., Love, J. D., Li, C., Banayo, E., Gooch, J. T., Krishna, V., Chatterjee, K., Evans, R. M., & Schwabe, J. W. R. (1999) · Genes & Development · doi:10.1101/gad.13.24.3209 · Cited by 417
Mechanism of the nuclear receptor molecular switch
NAGY, L. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.04.006 · Cited by 410
Hydrogen exchange and mass spectrometry: A historical perspective
Englander, S. W. (2006) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2006.06.006 · Cited by 404
Cronet, P., Petersen, J. F. W., Folmer, R., Blomberg, N., Sjöblom, K., Karlsson, U., Lindstedt, E.-L., & Bamberg, K. (2001) · Structure · doi:10.1016/s0969-2126(01)00634-7 · Cited by 325
Berger, J. P., Petro, A. E., Macnaul, K. L., Kelly, L. J., Zhang, B. B., Richards, K., Elbrecht, A., Johnson, B. A., Zhou, G., Doebber, T. W., et al. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0217 · Cited by 321
A peroxisome proliferator-activated receptor γ ligand inhibits adipocyte differentiation
Oberfield, J. L., Collins, J. L., Holmes, C. P., Goreham, D. M., Cooper, J. P., Cobb, J. E., Lenhard, J. M., Hull-Ryde, E. A., Mohr, C. P., Blanchard, S. G., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6102 · Cited by 316
Probing Protein Ligand Interactions by Automated Hydrogen/Deuterium Exchange Mass Spectrometry
Chalmers, M. J., Busby, S. A., Pascal, B. D., He, Y., Hendrickson, C. L., Marshall, A. G., & Griffin, P. R. (2006) · Analytical Chemistry · doi:10.1021/ac051294f · Cited by 301
Self-citationA Unique PPARγ Ligand with Potent Insulin-Sensitizing yet Weak Adipogenic Activity
Rocchi, S., Picard, F., Vamecq, J., Gelman, L., Potier, N., Zeyer, D., Dubuquoy, L., Bac, P., Champy, M.-F., Plunket, K. D., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00353-7 · Cited by 272
LIGAND CONTROL OF COREGULATOR RECRUITMENT TO NUCLEAR RECEPTORS
Nettles, K. W., & Greene, G. L. (2005) · Annual Review of Physiology · doi:10.1146/annurev.physiol.66.032802.154710 · Cited by 268
Self-citationCrystal Structure of the Ligand Binding Domain of the Human Nuclear Receptor PPARγ
Uppenberg, J., Svensson, C., Jaki, M., Bertilsson, G., Jendeberg, L., & Berkenstam, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.31108 · Cited by 260
A dynamic mechanism of nuclear receptor activation and its perturbation in a human disease
Kallenberger, B. C., Love, J. D., Chatterjee, V. K. K., & Schwabe, J. W. R. (2003) · Nature Structural Biology · doi:10.1038/nsb892 · Cited by 170
Johnson, B. A., Wilson, E. M., Li, Y., Moller, D. E., Smith, R. G., & Zhou, G. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.3636 · Cited by 165
Bendixen, A. C., Shevde, N. K., Dienger, K. M., Willson, T. M., Funk, C. D., & Pike, J. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041493198 · Cited by 161
Burgermeister, E., Schnoebelen, A., Flament, A., Benz, J., Stihle, M., Gsell, B., Rufer, A., Ruf, A., Kuhn, B., Märki, H. P., et al. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0171 · Cited by 160
Sauerberg, P., Pettersson, I., Jeppesen, L., Bury, P. S., Mogensen, J. P., Wassermann, K., Brand, C. L., Sturis, J., Wöldike, H. F., Fleckner, J., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010964g · Cited by 143
Benzoyl 2-methyl indoles as selective PPARγ modulators
Acton, J. J., Black, R. M., Jones, A. B., Moller, D. E., Colwell, L. F., Doebber, T. W., MacNaul, K. L., Berger, J. P., & Wood, H. B. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.10.068 · Cited by 129
Hydrogen/deuterium‐exchange (H/D‐Ex) of PPARγ LBD in the presence of various modulators
Hamuro, Y., Coales, S. J., Morrow, J. A., Molnar, K. S., Tuske, S. J., Southern, M. R., & Griffin, P. R. (2006) · Protein Science · doi:10.1110/ps.062103006 · Cited by 119
Self-citationEbdrup, S., Pettersson, I., Rasmussen, H. B., Deussen, H.-J., Jensen, A. F., Mortensen, S. B., Fleckner, J., Pridal, L., Nygaard, L., & Sauerberg, P. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm021027r · Cited by 117
Physiological and Therapeutic Roles of Peroxisome Proliferator-Activated Receptors
Berger, J. P., & Wagner, J. A. (2002) · Diabetes Technology & Therapeutics · doi:10.1089/15209150260007381 · Cited by 107
L-764406 Is a Partial Agonist of Human Peroxisome Proliferator-activated Receptor γ
Elbrecht, A., Chen, Y., Adams, A., Berger, J. P., Griffin, P. R., Klatt, T., Zhang, B., Menke, J. G., Zhou, G., Smith, R. G., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7913 · Cited by 102
Self-citationMahindroo, N., Huang, C.-F., Peng, Y.-H., Wang, C.-C., Liao, C. ‐., Lien, T., Chittimalla, S. K., Huang, W., Chai, C.-H., Prakash, E., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0506930 · Cited by 90
Protein Conformations, Interactions, and H/D Exchange
Maier, C. S., & Deinzer, M. L. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)02010-0 · Cited by 81
Networks for the allosteric control of protein kinases
Shi, Z., Resing, K. A., & Ahn, N. G. (2006) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2006.10.011 · Cited by 78
Östberg, T., Svensson, S., Selén, G., Uppenberg, J., Thor, M., Sundbom, M., Sydow‐Báckman, M., Gustavsson, A., & Jendeberg, L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401552200 · Cited by 78
Pascal, B., Chalmers, M. J., Busby, S., Mader, C., Southern, M. R., Tsinoremas, N. F., & Griffin, P. R. (2007) · BMC Bioinformatics · doi:10.1186/1471-2105-8-156 · Cited by 70
Self-citationRangwala, S. M., & Lazar, M. A. (2002) · Science Signaling · doi:10.1126/stke.2002.121.pe9 · Cited by 55
Fujimura, T., Sakuma, H., Konishi, S., Oe, T., Hosogai, N., Kimura, C., Aramori, I., & Mutoh, S. (2005) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0050578 · Cited by 39
Fujimura, T., Sakuma, H., Ohkubo‐Suzuki, A., Aramori, I., & Mutoh, S. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.423 · Cited by 27
Rosiglitazone: a new therapy for Type 2 diabetes
Greene, D. A. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.10.1709 · Cited by 23
Klein, F. A. C., Atkinson, R. A., Potier, N., Moras, D., & Cavarelli, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411697200 · Cited by 22
Cited by
Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5
Choi, J. H., Banks, A. S., Estall, J. L., Kajimura, S., Boström, P., Laznik, D., Ruas, J. L., Chalmers, M. J., Kamenecka, T. M., Blüher, M., et al. (2010) · Nature · doi:10.1038/nature09291 · Cited by 875
Self-citationStructure of the intact PPAR-γ–RXR-α nuclear receptor complex on DNA
Chandra, V., Huang, P., Hamuro, Y., Raghuram, S., Wang, Y., Burris, T. P., & Rastinejad, F. (2008) · Nature · doi:10.1038/nature07413 · Cited by 808
PPARγ agonists Induce a White-to-Brown Fat Conversion through Stabilization of PRDM16 Protein
Ohno, H., Shinoda, K., Spiegelman, B. M., & Kajimura, S. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.01.019 · Cited by 747
Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation
Choi, J. H., Banks, A. S., Kamenecka, T. M., Busby, S. A., Chalmers, M. J., Kumar, N., Kuruvilla, D. S., Shin, Y., He, Y., Bruning, J. B., et al. (2011) · Nature · doi:10.1038/nature10383 · Cited by 536
Self-citationStructural basis for the activation of PPARγ by oxidized fatty acids
Itoh, T., Fairall, L., Amin, K., Inaba, Y., Szanto, A., Balint, B. L., Nagy, L., Yamamoto, K., & Schwabe, J. W. R. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1474 · Cited by 457
Metadata
- Authors
- Bruning, J. B., Chalmers, M. J., Prasad, S., Busby, S. A., Kamenecka, T. M., He, Y., Nettles, K. W., & Griffin, P. R.
- Venue
- Structure
- Publisher
- Elsevier BV
- Published
- 2007-10
- Volume
- 15
- Issue
- 10
- Pages
- 1258-1271
- ISSN
- 0969-2126 (ISSN-L)
- OpenAlex
- W2083319939
- Cited by
- 389
- References
- 46
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.